Compare Sigachi Indust. with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate -7.84% of over the last 5 years
The company has declared Negative results for the last 3 consecutive quarters
Despite the size of the company, domestic mutual funds hold only 0% of the company
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
INR 966 Cr (Micro Cap)
27.00
37
0.39%
0.22
6.99%
1.89
Total Returns (Price + Dividend) 
Latest dividend: 0.09999999999999999 per share ex-dividend date: Sep-16-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Sigachi Industries Ltd Technical Momentum Shifts Amid Mixed Market Signals
Sigachi Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish signals on weekly charts, monthly indicators suggest caution, reflecting a complex technical landscape for investors to navigate.
Read full news article
Sigachi Industries Ltd Technical Momentum Shifts Amid Mixed Market Signals
Sigachi Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock exhibits a complex interplay of bullish and bearish signals across key technical indicators, reflecting a nuanced market sentiment as it trades near ₹26.00.
Read full news article
Sigachi Industries Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
Sigachi Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a nuanced shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest day gain of 2.24%, the stock’s broader technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes, reflecting both cautious optimism and underlying weakness.
Read full news article Announcements 
Cancellation of Board Meeting
26-Jul-2026 | Source : BSEThe Board Meeting to be held on 27/07/2026 Stands Cancelled.
Postponement Of Earnings Call For Q1 FY 2026-27 Results
26-Jul-2026 | Source : BSEPostponement of earnings Call for Q1 FY 2026-27 results
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended June 30 2026
21-Jul-2026 | Source : BSESigachi Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2026 inter alia to consider and approve Board Meeting to be held on July 27 2026 for approval of Unaudited Financial Results for the Quarter ended June 30 2026
Corporate Actions 
No Upcoming Board Meetings
Sigachi Industries Ltd has declared 10% dividend, ex-date: 16 Sep 25
Sigachi Industries Ltd has announced 1:10 stock split, ex-date: 09 Oct 23
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Non Institution
20.0439
Held by 2 Schemes (0.0%)
Held by 11 FIIs (1.25%)
Rps Industries Private Limited (15.02%)
Rakesh Yadav (2.65%)
54.23%
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 4.00% vs 6.09% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 3,755.00% vs -98.13% in Dec 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 8.21% vs 19.98% in Sep 2024
Growth in half year ended Sep 2025 is -356.64% vs 34.44% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -1.14% vs 22.12% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -258.94% vs 33.71% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -2.13% vs 22.38% in Mar 2025
YoY Growth in year ended Mar 2026 is -217.54% vs 21.65% in Mar 2025






